Literature DB >> 31381966

Evaluation of diacetyl mediated pulmonary effects in physiologically relevant air-liquid interface models of human primary bronchial epithelial cells.

Tania A Thimraj1, Shanzina I Sompa2, Koustav Ganguly3, Lena Ernstgård4, Gunnar Johanson5, Lena Palmberg6, Swapna Upadhyay7.   

Abstract

Diacetyl is an artificial flavouring agent, known to cause bronchiolitis obliterans. Diacetyl-induced pulmonary effects were assessed in human primary bronchial epithelial cells (PBEC) cultured at air-liquid interface (ALI). The PBEC-ALI models were exposed to clean air (sham) and diacetyl vapour (1, 3, 10 and 30 ppm) for 30 min. At 6 and 24 h post-exposure, cell medium was sampled for assessment of cytotoxicity measurement, and CXCL8, MMP9 secretion by ELISA. Pro-inflammatory, oxidative stress, tissue injury/repair, anti-protease and beta-defensin markers were assessed using qRT-PCR. Additionally, epidermal growth factor receptor ligands (amphiregulin) and anti-protease (SLPI) were analysed at 6 h, 8 h and 24 h post exposure to 1 and 10 ppm diacetyl. No significant cytotoxicity was observed at any exposure level. MMP9 was significantly increased in both apical and basal media at 24 h. Both SLPI and amphiregulin secretion were significantly increased following exposure to 10 ppm diacetyl. Exposure of PBEC-ALI model to diacetyl vapour resulted in significantly altered transcript expression of pro-inflammatory, oxidative stress, anti-protease, tissue injury/repair markers. Changes in transcript expression of significantly altered markers were more prominent 24 h post-exposure compared to 6 h. This study warrants further mechanistic investigations to elucidate the pulmonary effects of inhaled diacetyl vapour using physiologically relevant in vitro models.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31381966     DOI: 10.1016/j.tiv.2019.104617

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  5 in total

1.  Addressing the challenges of E-cigarette safety profiling by assessment of pulmonary toxicological response in bronchial and alveolar mucosa models.

Authors:  Koustav Ganguly; Axel Nordström; Tania A Thimraj; Mizanur Rahman; Malin Ramström; Shanzina I Sompa; Elizabeth Z Lin; Fiona O'Brien; Jeremy Koelmel; Lena Ernstgård; Gunnar Johanson; Krystal J Godri Pollitt; Lena Palmberg; Swapna Upadhyay
Journal:  Sci Rep       Date:  2020-11-24       Impact factor: 4.379

2.  Differential Effect of SARS-CoV-2 Spike Glycoprotein 1 on Human Bronchial and Alveolar Lung Mucosa Models: Implications for Pathogenicity.

Authors:  Mizanur Rahman; Martin Irmler; Sandeep Keshavan; Micol Introna; Johannes Beckers; Lena Palmberg; Gunnar Johanson; Koustav Ganguly; Swapna Upadhyay
Journal:  Viruses       Date:  2021-12-17       Impact factor: 5.048

3.  Establishment of Repeated In Vitro Exposure System for Evaluating Pulmonary Toxicity of Representative Criteria Air Pollutants Using Advanced Bronchial Mucosa Models.

Authors:  Swapna Upadhyay; Ashesh Chakraborty; Tania A Thimraj; Marialuisa Baldi; Anna Steneholm; Koustav Ganguly; Per Gerde; Lena Ernstgård; Lena Palmberg
Journal:  Toxics       Date:  2022-05-24

4.  Insight into the pulmonary molecular toxicity of heated tobacco products using human bronchial and alveolar mucosa models at air-liquid interface.

Authors:  Swapna Upadhyay; Koustav Ganguly; Mizanur Rahman; Martin Irmler; Micol Introna; Johannes Beckers; Lena Palmberg; Gunnar Johanson
Journal:  Sci Rep       Date:  2022-09-30       Impact factor: 4.996

5.  Analysis of Acrolein Exposure Induced Pulmonary Response in Seven Inbred Mouse Strains and Human Primary Bronchial Epithelial Cells Cultured at Air-Liquid Interface.

Authors:  Gunnar Johanson; Aishwarya Mishra Dwivedi; Lena Ernstgård; Lena Palmberg; Koustav Ganguly; Lung Chi Chen; Karen Galdanes; Terry Gordon; Swapna Upadhyay
Journal:  Biomed Res Int       Date:  2020-10-08       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.